Internal Medicine, Nephrology · Memphis, TN
NPI
1164554572
Since 2007
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
0
Medicare group memberships
Hospitals
3
Hospital affiliations
2225 Union Ave Ste 100
Memphis, TN, 38104
Phone (901) 726-1161
Medicare paid, 2024
$210K
2,478 services
Medicare patients, 2024
596
Average age 73
Drug cost, 2024
$1.0M
2,438 prescriptions
Company payments, 2025
$954
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fadi Daher was code 99232 (hospital e&m - subsequent), 968 times for 294 patients. In total Fadi Daher billed 2,478 services in 16 codes, and Medicare paid $210K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 968 | 294 | $57.21 | $55K |
| 99214 Office E&M - Established | Office | 272 | 166 | $90.51 | $25K |
| 99222 Hospital E&M - Initial | Facility | 201 | 168 | $91.03 | $18K |
| 99231 Hospital E&M - Subsequent | Facility | 197 | 75 | $35.22 | $6,939 |
| 90960 ESRD Related Services (not dialysis) | Office | 180 | 32 | $259.12 | $47K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 171 | 142 | $12.03 | $2,057 |
| 99213 Office E&M - Established | Office | 119 | 100 | $54.45 | $6,480 |
| 90935 Hemodialysis | Facility | 105 | 60 | $50.64 | $5,317 |
| 90961 ESRD Related Services (not dialysis) | Office | 64 | 28 | $214.72 | $14K |
| 99204 Office E&M - New | Office | 43 | 43 | $113.40 | $4,876 |
| 90962 ESRD Related Services (not dialysis) | Office | 41 | 19 | $144.49 | $5,924 |
| 99223 Hospital E&M - Initial | Facility | 38 | 37 | $124.82 | $4,743 |
By year: 2022 $266K for 3,160 services; 2023 $240K for 2,924 services; 2024 $210K for 2,478 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fadi Daher prescribed most often to Medicare patients was Velphoro (Sucroferric Oxyhydroxide), with 253 prescriptions and refills. In total Fadi Daher wrote 2,438 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Velphoro Sucroferric Oxyhydroxide | 253 | 287 | 57 | $596K |
| Amlodipine Besylate Generic | 203 | 563 | 85 | $1,013 |
| Furosemide Generic | 164 | 403 | 68 | $887 |
| Sevelamer Carbonate Generic | 152 | 238 | 49 | $26K |
| Hydralazine Hcl Generic | 102 | 230 | 42 | $2,016 |
| Calcitriol Generic | 99 | 238 | 35 | $1,482 |
| Carvedilol Generic | 86 | 204 | 34 | $572 |
| Clonidine Hcl Generic | 86 | 221 | 38 | $563 |
| Fluconazole Generic | 60 | 60 | 40 | $185 |
| Losartan Potassium Generic | 56 | 152 | 24 | $379 |
| Lokelma Sodium Zirconium Cyclosilicate | 56 | 100 | 26 | $47K |
| Lisinopril Generic | 54 | 158 | 18 | $306 |
| Januvia Sitagliptin Phosphate | 50 | 80 | 14 | $42K |
| Gabapentin Generic | 49 | 55 | 18 | $174 |
| Farxiga Dapagliflozin Propanediol | 48 | 102 | 17 | $52K |
Brand drugs: - claims; generic drugs: 1,856 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fadi Daher $954 ($954 in general payments such as food, travel and fees) from 13 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $231.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 10 | $231 |
| Travere Therapeutics, Inc. TVTX | 9 | $128 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $110 |
| Ardelyx, Inc. ARDX | 3 | $80.6 |
| Calliditas Therapeutics US Inc. | 3 | $73.05 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $67.28 |
| Vifor Pharma, Inc. | 2 | $39.62 |
| Fresenius USA Marketing, Inc. | 2 | $36.4 |
| OPKO Pharmaceuticals, LLC | 1 | $21.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.